FABP4 Enhances Lipidic and Fibrotic Cardiac Structural and Ca(2+) Dynamic Changes.
Couselo-Seijas M, Vázquez-Abuín X, Gómez-Lázaro M, Pereira L, Gómez AM, Caballero R, Delpón E, Bravo S, González-Juanatey JR, Eiras S.

Fatty Acid Binding Protein-4 Silencing Inhibits Ferroptosis to Alleviate Lipopolysaccharide-induced Injury of Renal Tubular Epithelial Cells by Blocking Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling.
Xu S, Luo J, Wang Y, Chen X.

Fatty Acid-Binding Protein 4-Mediated Regulation Is Pivotally Involved in Retinal Pathophysiology: A Review.
Ohguro H, Watanabe M, Hikage F, Sato T, Nishikiori N, Umetsu A, Higashide M, Ogawa T, Furuhashi M., Free PMC Article

Concomitant decrease of E- and A-FABP expression predicts worse survival in urothelial bladder cancer patients.
Saizonou I, Lascombe I, Monnien F, Bedgedjian I, Kleinclauss F, Algros MP, Fauconnet S., Free PMC Article

Fatty acid binding to the human transport proteins FABP3, FABP4, and FABP5 from a Ligand's perspective.
Michler S, Schöffmann FA, Robaa D, Volmer J, Hinderberger D., Free PMC Article

Association of fatty acid binding protein-4 (FABP-4) T87C and rs8192688 gene polymorphisms and FABP-4 level with cardiovascular disease susceptibility in type 2 diabetic patients.
Bakhtiyari A, Bakhtiyari S, Peymani M, Haghani K, Norozi S.

NKX2-1-AS1 promotes the lymphangiogenesis of lung adenocarcinoma through regulation of ERG-mediated FABP4.
Tao T, Chen H, Xu Q, Li Z, Chen X, Zhou X, Luo W.

Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease.
Zhao Z, Fu Y, Lian H, Liu Y, Liu J, Sun L, Zhang Y., Free PMC Article

Circulating FABP-4 Levels in Patients with Atherosclerosis or Coronary Artery Disease: A Comprehensive Systematic Review and Meta-Analysis.
Jalilian N, Pakzad R, Shahbazi M, Edrisi SR, Haghani K, Jalilian M, Bakhtiyari S., Free PMC Article

Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer.
Nimptsch K, Aleksandrova K, Pham TT, Papadimitriou N, Janke J, Christakoudi S, Heath A, Olsen A, Tjønneland A, Schulze MB, Katzke V, Kaaks R, van Guelpen B, Harbs J, Palli D, Macciotta A, Pasanisi F, Yohar SMC, Guevara M, Amiano P, Grioni S, Jakszyn PG, Figueiredo JC, Samadder NJ, Li CI, Moreno V, Potter JD, Schoen RE, Um CY, Weiderpass E, Jenab M, Gunter MJ, Pischon T., Free PMC Article

Adipose tissue-derived FABP4 mediates glucagon-stimulated hepatic glucose production in gestational diabetes.
Ron I, Mdah R, Zemet R, Ulman RY, Rathaus M, Brandt B, Mazaki-Tovi S, Hemi R, Barhod E, Tirosh A.

Pathophysiological Insight into Fatty Acid-Binding Protein-4: Multifaced Roles in Reproduction, Pregnancy, and Offspring Health.
Shi Y, Wang CC, Wu L, Zhang Y, Xu A, Wang Y., Free PMC Article

The Association and Joint Effect of Adipocyte Fatty Acid Binding Protein and Obesity Phenotype With Cardiovascular Events.
Hu T, Shen Y, Cao W, Xu Y, Wang Y, Bao Y, Ma X., Free PMC Article

Fatty acid binding protein 4 has prognostic value in peripheral artery disease.
Li B, Zamzam A, Syed MH, Djahanpour N, Jain S, Abdin R, Qadura M.

Desmoglein 2 Functions as a Receptor for Fatty Acid Binding Protein 4 in Breast Cancer Epithelial Cells.
Chen D, Wirth KM, Kizy S, Muretta JM, Markowski TW, Yong P, Sheka A, Abdelwahab H, Hertzel AV, Ikramuddin S, Yamamoto M, Bernlohr DA., Free PMC Article

Endothelial-derived FABP4 constitutes the majority of basal circulating hormone and regulates lipolysis-driven insulin secretion.
Inouye KE, Prentice KJ, Lee A, Wang ZB, Dominguez-Gonzalez C, Chen MX, Riveros JK, Burak MF, Lee GY, Hotamışlıgil GS., Free PMC Article

Inhibition of Fatty Acid β-Oxidation by Fatty Acid Binding Protein 4 Induces Ferroptosis in HK2 Cells Under High Glucose Conditions.
Chen J, Wu K, Lei Y, Huang M, Cheng L, Guan H, Lin J, Zhong M, Wang X, Zheng Z., Free PMC Article

Glomerular expression and urinary excretion of fatty acid-binding protein 4 in IgA nephropathy.
Tanaka M, Moniwa N, Nogi C, Kano T, Matsumoto M, Sakai A, Maeda T, Takizawa H, Ogawa Y, Asanuma K, Suzuki Y, Furuhashi M.

Ferroptosis, Acyl Starvation, and Breast Cancer.
Bobiński R, Dutka M, Pizon M, Waksmańska W, Pielesz A.

FABP4 Controls Fat Mass Expandability (Adipocyte Size and Number) through Inhibition of CD36/SR-B2 Signalling.
Berger E, Géloën A., Free PMC Article

Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH).
Wagner J, Kumar Y, Lautenbach A, von Kroge P, Wolter S, Mann O, Izbicki J, Gagliani N, Duprée A., Free PMC Article

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids.
Atilano-Miguel S, Barbosa-Cortés L, Ortiz-Muñiz R.

mTOR-FABP4 signal is activated in brain arteriovenous malformations in humans.
Yan D, Hao Q, Chen Y, Li Z, Zhang H, Yuan K, Li R, Li R, Zhao Y, Wang K, Peng H, Zhang D, Chen X, Zhao Y.

Fatty Acid-Binding Protein 4 in Patients with and without Diabetic Retinopathy.
Huang P, Zhao X, Sun Y, Wang X, Ouyang R, Jiang Y, Zhang X, Hu R, Tang Z, Gu Y., Free PMC Article

Serum adipocyte fatty acid-binding protein level is positively associated with aortic stiffness in nondialysis chronic kidney disease patients: A cross-sectional study.
Su HY, Hsu BG, Lin YL, Wang CH, Lai YH., Free PMC Article